002728 特一药业
已收盘 09-03 15:00:00
资讯
新帖
简况
特一药业公布国际专利申请：“一种双氯芬酸钠肠溶片的压片机出片装置及制备工艺”
证券之星 · 08-29
特一药业公布国际专利申请：“一种双氯芬酸钠肠溶片的压片机出片装置及制备工艺”
特一药业（002728）2025年中报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 08-22
特一药业（002728）2025年中报简析：营收净利润同比双双增长，三费占比上升明显
盘前公告淘金：国药承诺5年内整合天坛生物与派林生物；特一药业、千方科技上半年净利润大增超10倍；中国石化拟5亿元-10亿元回购公司A股股份
金融界 · 08-22
盘前公告淘金：国药承诺5年内整合天坛生物与派林生物；特一药业、千方科技上半年净利润大增超10倍；中国石化拟5亿元-10亿元回购公司A股股份
股市必读：特一药业中报 - 第二季度单季净利润同比增长199.62%
证券之星 · 08-21
股市必读：特一药业中报 - 第二季度单季净利润同比增长199.62%
特一药业公布半年报 上半年净利增加1313.23%
新浪财经-鹰眼工作室 · 08-21
特一药业公布半年报 上半年净利增加1313.23%
图解特一药业中报：第二季度单季净利润同比增长199.62%
证券之星 · 08-21
图解特一药业中报：第二季度单季净利润同比增长199.62%
特一药业：上半年净利3800.77万元，同比增1313.23%
格隆汇 · 08-21
特一药业：上半年净利3800.77万元，同比增1313.23%
特一药业：2025年上半年净利润同比增长1,313.23%
金融界 · 08-21
特一药业：2025年上半年净利润同比增长1,313.23%
特一药业：深化营销改革提升品牌竞争力
证券之星 · 08-21
特一药业：深化营销改革提升品牌竞争力
特一药业：公司持有替加氟胶囊药品批文
证券之星 · 08-08
特一药业：公司持有替加氟胶囊药品批文
特一药业：公司营销组织变革正在持续推进
证券之星 · 07-31
特一药业：公司营销组织变革正在持续推进
特一药业：在中成药和化学药研发方面推行双向并举
证券之星 · 07-21
特一药业：在中成药和化学药研发方面推行双向并举
特一药业最新公告：选举许荣煌为董事长并聘任高级管理人员
证券之星 · 07-16
特一药业最新公告：选举许荣煌为董事长并聘任高级管理人员
7月16日特一药业涨5.49%，兴全中证800六个月持有指数A基金重仓该股
证券之星 · 07-16
7月16日特一药业涨5.49%，兴全中证800六个月持有指数A基金重仓该股
特一药业股价下跌2.02% 临时股东大会明日召开
金融界 · 07-15
特一药业股价下跌2.02% 临时股东大会明日召开
特一药业：预计2025年1-6月每股收益盈利:0.07元至0.08元
证券之星 · 07-14
特一药业：预计2025年1-6月每股收益盈利:0.07元至0.08元
特一药业收盘上涨1.83%，滚动市盈率106.56倍，总市值45.72亿元
金融界 · 07-14
特一药业收盘上涨1.83%，滚动市盈率106.56倍，总市值45.72亿元
特一药业：选举姚如卿女士为第六届董事会职工代表董事
证券日报网 · 06-30
特一药业：选举姚如卿女士为第六届董事会职工代表董事
特一药业：公司药库防洪防汛措施完备确保药品安全
证券之星 · 06-26
特一药业：公司药库防洪防汛措施完备确保药品安全
特一药业：公司在中成药和化学药研发方面推行双向并举
证券之星 · 06-24
特一药业：公司在中成药和化学药研发方面推行双向并举
加载更多
公司概况
公司名称：
特一药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2014-07-31
主营业务：
特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品包括止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒等。
发行价格：
14.00
{"stockData":{"symbol":"002728","market":"SZ","secType":"STK","nameCN":"特一药业","latestPrice":8.78,"timestamp":1756882998000,"preClose":9.03,"halted":0,"volume":10787111,"delay":0,"changeRate":-0.0277,"floatShares":376000000,"shares":513000000,"eps":0.1089,"marketStatus":"已收盘","change":-0.25,"latestTime":"09-03 15:00:00","open":9.03,"high":9.08,"low":8.77,"amount":96251200,"amplitude":0.0343,"askPrice":8.79,"askSize":384,"bidPrice":8.78,"bidSize":385,"shortable":0,"etf":0,"ttmEps":0.1089,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756949400000},"marketStatusCode":5,"adr":0,"adjPreClose":9.03,"symbolType":"stock","openAndCloseTimeList":[[1756863000000,1756870200000],[1756875600000,1756882800000]],"highLimit":9.93,"lowLimit":8.13,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":512661866,"isCdr":false,"pbRate":2.61,"roa":"--","peRate":80.624426,"roe":"2.13%","epsLYR":0.04,"committee":-0.161199,"marketValue":4501000000,"turnoverRate":0.0287,"status":1,"floatMarketCap":3305000000},"requestUrl":"/m/hq/s/002728","defaultTab":"news","newsList":[{"id":"2563652077","title":"特一药业公布国际专利申请：“一种双氯芬酸钠肠溶片的压片机出片装置及制备工艺”","url":"https://stock-news.laohu8.com/highlight/detail?id=2563652077","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563652077?lang=zh_cn&edition=full","pubTime":"2025-08-30 05:38","pubTimestamp":1756503506,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示特一药业（002728）公布了一项国际专利申请，专利名为“一种双氯芬酸钠肠溶片的压片机出片装置及制备工艺”，专利申请号为PCT/CN2024/097026，国际公布日为2025年8月28日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来特一药业已公布的国际专利申请1个，与去年同期持平。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了1915.59万元，同比减11.55%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000009569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2561285464","title":"特一药业（002728）2025年中报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2561285464","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561285464?lang=zh_cn&edition=full","pubTime":"2025-08-23 06:14","pubTimestamp":1755900874,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期特一药业发布2025年中报。截至本报告期末，公司营业总收入4.91亿元，同比上升56.54%，归母净利润3800.77万元，同比上升1313.23%。本报告期特一药业三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达39.42%。所得税费用变动幅度为730.76%,原因:高毛利率中药产品收入同比显著增长，公司利润水平得到提升。2025年一季度，止咳宝片销量达到了 2.17亿片，呈现良好的恢复态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082300006557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2561410485","title":"盘前公告淘金：国药承诺5年内整合天坛生物与派林生物；特一药业、千方科技上半年净利润大增超10倍；中国石化拟5亿元-10亿元回购公司A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2561410485","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561410485?lang=zh_cn&edition=full","pubTime":"2025-08-22 08:23","pubTimestamp":1755822181,"startTime":"0","endTime":"0","summary":"【重要事项】兰石重装：投资2.07亿元建设青岛核电装备产能提升项目先导智能：已成功输出量产级固态电池整线方案，相关产品已陆续获得重复订单盛视科技：投资设立全资子公司，旨在将AI、人形机器人技术与潮玩创新结合泽璟制药：注射用ZG005、注射用ZGGS18与盐酸吉卡昔替尼片联用获得药物临床试验批准通知书天坛生物：国药集团及中国生物承诺解决与公司新增同业竞争问题长春高新：子公司注射用GenSci143注","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/08/22082352601206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159982","600028","002728","000403","399300","002373","600161"],"gpt_icon":0},{"id":"2561750413","title":"股市必读：特一药业中报 - 第二季度单季净利润同比增长199.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561750413","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561750413?lang=zh_cn&edition=full","pubTime":"2025-08-22 03:24","pubTimestamp":1755804258,"startTime":"0","endTime":"0","summary":"截至2025年8月21日收盘，特一药业报收于9.46元，上涨0.85%，换手率6.45%，成交量24.29万手，成交额2.28亿元。业绩披露要点: 特一药业2025年中报显示，归母净利润同比增长1313.23%，扣非净利润同比增长6095.52%。交易信息汇总8月21日，特一药业的资金流向情况如下：主力资金净流入1424.74万元；游资资金净流入296.32万元；散户资金净流出1721.07万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200004377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2561667254","title":"特一药业公布半年报 上半年净利增加1313.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561667254","media":"新浪财经-鹰眼工作室","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561667254?lang=zh_cn&edition=full","pubTime":"2025-08-21 18:21","pubTimestamp":1755771660,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 8月21日消息，特一药业发布半年度报告。 公告显示，公司半年度营业收入491,142,874.06元，同比增加56.54%，归属上市公司股东的净利润38,007,729.88元，同比增加1313.23%。 公告显示，十大流通股东中，香港中央结算有限公司、中信证券股份有限公司为新进流通股东。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-08-21/doc-infmtwex9368740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2561383465","title":"图解特一药业中报：第二季度单季净利润同比增长199.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561383465","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561383465?lang=zh_cn&edition=full","pubTime":"2025-08-21 17:47","pubTimestamp":1755769625,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业2025年中报显示，公司主营收入4.91亿元，同比上升56.54%；归母净利润3800.77万元，同比上升1313.23%；扣非净利润3808.53万元，同比上升6095.52%；其中2025年第二季度，公司单季度主营收入1.96亿元，同比上升31.43%；单季度归母净利润644.05万元，同比上升199.62%；单季度扣非净利润637.84万元，同比上升176.76%；负债率22.04%，投资收益29.97万元，财务费用159.79万元，毛利率60.23%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100030177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2561946896","title":"特一药业：上半年净利3800.77万元，同比增1313.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561946896","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561946896?lang=zh_cn&edition=full","pubTime":"2025-08-21 17:14","pubTimestamp":1755767692,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2561468305","title":"特一药业：2025年上半年净利润同比增长1,313.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561468305","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561468305?lang=zh_cn&edition=full","pubTime":"2025-08-21 17:12","pubTimestamp":1755767556,"startTime":"0","endTime":"0","summary":"特一药业公告，2025年上半年营业收入4.91亿元，同比增长56.54%。净利润3800.77万元，同比增长1,313.23%。公司计划不派发现金红利，不送红股，不以公积金转增股本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/21171252589927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002728"],"gpt_icon":0},{"id":"2561997435","title":"特一药业：深化营销改革提升品牌竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2561997435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561997435?lang=zh_cn&edition=full","pubTime":"2025-08-21 08:45","pubTimestamp":1755737117,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业08月20日在投资者关系平台上答复投资者关心的问题。特一药业在2024年之前一直采用经销商模式，由代理商负责在各区域对药店进行市场推广与宣传。公司也将继续深化营销体系改革，加强品牌建设，不断拓展产品市场覆盖面。再次感谢您对特一药业及公司产品的认可与支持！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100005073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2557545917","title":"特一药业：公司持有替加氟胶囊药品批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2557545917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557545917?lang=zh_cn&edition=full","pubTime":"2025-08-08 15:21","pubTimestamp":1754637678,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业(002728)08月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司有扛癌药物吗？谢谢特一药业回复：您好，感谢您对公司的关注。在抗癌类药物方面，公司持有替加氟胶囊（国药准字H44024239）的药品批文，适用于消化道肿瘤，如胃癌、结肠癌和胰腺癌，也可用于乳腺癌、支气管肺癌和原发性肝癌等。公司目前暂未生产、销售。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080800018914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"gpt_icon":0},{"id":"2555640002","title":"特一药业：公司营销组织变革正在持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2555640002","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555640002?lang=zh_cn&edition=full","pubTime":"2025-07-31 15:57","pubTimestamp":1753948634,"startTime":"0","endTime":"0","summary":"关于止咳宝片供应问题：公司营销组织变革正在持续推进，止咳宝片销售市场处于恢复阶段，部分区域的药店覆盖尚在完善中。目前，公司与全国及区域连锁的合作已正常开展。关于创新药研发：公司秉持中成药与化学药研发“双向并举”的策略，持续稳步推进创新药物研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073100023135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2553214054","title":"特一药业：在中成药和化学药研发方面推行双向并举","url":"https://stock-news.laohu8.com/highlight/detail?id=2553214054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553214054?lang=zh_cn&edition=full","pubTime":"2025-07-21 15:48","pubTimestamp":1753084090,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业07月21日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072100016851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2551938140","title":"特一药业最新公告：选举许荣煌为董事长并聘任高级管理人员","url":"https://stock-news.laohu8.com/highlight/detail?id=2551938140","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551938140?lang=zh_cn&edition=full","pubTime":"2025-07-16 19:39","pubTimestamp":1752665967,"startTime":"0","endTime":"0","summary":"特一药业(002728.SZ)公告称，公司第六届董事会第一次会议选举许荣煌为董事长，任期与本届董事会任期相同。同时，会议还聘任许荣煌为总经理，陈习良为副总经理和财务总监，许紫兰为董事会秘书。此外，会议还选举了董事会各专门委员会成员，并聘任了其他高级管理人员和证券事务代表。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600033118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2551459791","title":"7月16日特一药业涨5.49%，兴全中证800六个月持有指数A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551459791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551459791?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:13","pubTimestamp":1752653637,"startTime":"0","endTime":"0","summary":"证券之星消息，7月16日特一药业涨5.49%创60日新高，收盘报9.22元，换手率19.52%，成交量73.48万手，成交额6.81亿元。重仓特一药业的公募基金请见下表：根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为兴证全球基金的兴全中证800六个月持有指数A。兴全中证800六个月持有指数A目前规模为10.47亿元，最新净值1.1705，较上一交易日下跌0.26%，近一年上涨28.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600025239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159800","BK0239","000906.SH","002728","BK0201"],"gpt_icon":0},{"id":"2551910971","title":"特一药业股价下跌2.02% 临时股东大会明日召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2551910971","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551910971?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:41","pubTimestamp":1752604919,"startTime":"0","endTime":"0","summary":"截至2025年7月15日收盘，特一药业股价报8.74元，较前一交易日下跌0.18元，跌幅2.02%。当日成交量为48.69万手，成交额达4.27亿元。特一药业属于中药行业，公司主营业务涵盖中成药、化学药制剂等产品的研发、生产和销售。公司将于2025年7月16日召开临时股东大会，审议变更注册资本、修订公司章程、董事薪酬方案及董事会换届选举等议案。7月15日，特一药业主力资金净流入2688.42万元。风险提示：股市有风险，投资需谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/16024151721512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2551902107","title":"特一药业：预计2025年1-6月每股收益盈利:0.07元至0.08元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551902107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551902107?lang=zh_cn&edition=full","pubTime":"2025-07-14 18:08","pubTimestamp":1752487699,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业发布业绩预告，预计2025年1-6月每股收益盈利:0.07元至0.08元。特一药业集团股份有限公司董事会2025 年 7 月 15 日特一药业2025年一季报显示，公司主营收入2.95亿元，同比上升79.29%；归母净利润3156.73万元，同比上升244.82%；扣非净利润3170.69万元，同比上升255.28%；负债率19.06%，投资收益18.64万元，财务费用95.6万元，毛利率64.72%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400029355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"gpt_icon":0},{"id":"2551906768","title":"特一药业收盘上涨1.83%，滚动市盈率106.56倍，总市值45.72亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551906768","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551906768?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:47","pubTimestamp":1752482870,"startTime":"0","endTime":"0","summary":"7月14日，特一药业今日收盘8.92元，上涨1.83%，滚动市盈率PE达到106.56倍，创26天以来新低，总市值45.72亿元。从行业市盈率排名来看，公司所处的中药行业市盈率平均32.19倍，行业中值27.42倍，特一药业排名第61位。资金流向方面，7月14日，特一药业主力资金净流入279.47万元，近5日总体呈流入状态，5日共流入548.47万元。最新一期业绩显示，2025年一季报，公司实现营业收入2.95亿元，同比79.29%；净利润3156.73万元，同比244.82%，销售毛利率64.72%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14164751676485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2547045018","title":"特一药业：选举姚如卿女士为第六届董事会职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2547045018","media":"证券日报网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547045018?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:10","pubTimestamp":1751292600,"startTime":"0","endTime":"0","summary":"证券日报网讯6月30日晚间，特一药业发布公告称，公司于2025年6月27日召开了职工代表大会，经与会职工代表审议，一致同意选举姚如卿女士担任公司第六届董事会职工代表董事，任期三年，与公司第六届董事会任期一致。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-06-30/doc-infcwksi6214265.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-06-30/doc-infcwksi6214265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2546067222","title":"特一药业：公司药库防洪防汛措施完备确保药品安全","url":"https://stock-news.laohu8.com/highlight/detail?id=2546067222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546067222?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:18","pubTimestamp":1750922290,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业(002728)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问：南方部分地区水势较猛，汛期贵司的药品配备是否充足?特一药业回复：您好！感谢您对公司的关注。公司的药库严格遵循GSP规范，在仓储建设时，就有防洪防汛方面的措施，包括仓库设计、应急预案等，以确保药品质量、安全及仓储设施的正常运行。此外，公司根据市场需求合理排产，保证安全库存以满足市场需求。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600018983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2545287080","title":"特一药业：公司在中成药和化学药研发方面推行双向并举","url":"https://stock-news.laohu8.com/highlight/detail?id=2545287080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545287080?lang=zh_cn&edition=full","pubTime":"2025-06-24 20:54","pubTimestamp":1750769647,"startTime":"0","endTime":"0","summary":"证券之星消息，特一药业06月23日在投资者关系平台上答复投资者关心的问题。你就没考虑过公司自己研发或收购原创创新药独角兽公司吗？我想你也不希望特一每年利润就在一两千万元人民币上徘徊是吧？谢谢特一药业回复：您好，感谢您对公司的关注！同时，公司也寻求外延式的发展，如有合适的优质标的，公司不排除考虑并购或联合经营，提升公司综合竞争力和整体抵御市场波动的能力，实现持续稳定发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400037050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1756911876537,"stockEarnings":[{"period":"1week","weight":-0.0394},{"period":"1month","weight":-0.0475},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1262},{"period":"1year","weight":0.2503},{"period":"ytd","weight":0.0143}],"compareEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":0.0838},{"period":"3month","weight":0.1427},{"period":"6month","weight":0.1411},{"period":"1year","weight":0.3725},{"period":"ytd","weight":0.1511}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"特一药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"52800人(较上一季度减少16.38%)","perCapita":"7130股","listingDate":"2014-07-31","address":"广东省江门市台山市台城长兴路9、11号","registeredCapital":"51266万元","survey":" 特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品包括止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒等。","listedPrice":14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特一药业,002728,特一药业股票,特一药业股票老虎,特一药业股票老虎国际,特一药业行情,特一药业股票行情,特一药业股价,特一药业股市,特一药业股票价格,特一药业股票交易,特一药业股票购买,特一药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}